UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

8051 soc design based on fpga

Nong, Ying Xiong

2008

Volltextzugriff (PDF)

Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial

Journal of clinical oncology, 2013-09, Vol.31 (26), p.3219-3225

2013

Volltextzugriff (PDF)

A Strategy to Control Transmission of Schistosoma japonicum in China

The New England journal of medicine, 2009-01, Vol.360 (2), p.121-128

2009

Volltextzugriff (PDF)

2019 Chinese Hypertension League guidelines on home blood pressure monitoring

The journal of clinical hypertension (Greenwich, Conn.), 2020-03, Vol.22 (3), p.378-383

2020

Volltextzugriff (PDF)

2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension

Journal of geriatric cardiology : JGC, 2019-03, Vol.16 (3), p.182-241

2019

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

Journal of clinical oncology, 2016-05, Vol.34 (13), p.1448-1454

2016

Volltextzugriff (PDF)

Analysis of Protein Expression Patterns of Silkworm Jinqiu and Its Cross Parents

Agricultural sciences in China, 2009-09, Vol.8 (9), p.1130-1137

2009

Volltextzugriff (PDF)

Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial

Journal of clinical oncology, 2018-10, Vol.36 (30), p.3031-3039

2018

Volltextzugriff (PDF)

Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study

Journal of hematology and oncology, 2017-09, Vol.10 (1), p.153-153, Article 153

2017

Volltextzugriff (PDF)

Transarterial Chemoembolization Using 100-μm Drug-Eluting Microspheres in Patients with Hepatocellular Carcinoma: A Prospective Study and Midterm Follow-up

Journal of vascular and interventional radiology, 2020-11, Vol.31 (11), p.1784-1791

2020

Volltextzugriff (PDF)

Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double‐Blinded, Placebo‐Controlled, Randomized Phase III Trial (ALTER0703)

The oncologist (Dayton, Ohio), 2021-10, Vol.26 (10), p.e1693-e1703

2021

Volltextzugriff (PDF)

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma

Frontiers in oncology, 2020-09, Vol.10, p.1568-1568

2020

Volltextzugriff (PDF)

Phase Ia/Ib dose-escalation study of IBI110 (anti-LAG-3 mAb) as a single agent and in combination with sintilimab (anti-PD-1 mAb) in patients (pts) with advanced solid tumors

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2589-2589

2021

Volltextzugriff (PDF)

Efficacy and safety of IBI110 (anti-LAG-3 mAb) in combination with sintilimab (anti-PD-1 mAb) in first-line advanced squamous non-small cell lung cancer (sqNSCLC): Initial results from a phase Ib study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21145-e21145

2022

Volltextzugriff (PDF)

IBI110 (anti-LAG-3 mAb) as a single agent or in combination with sintilimab (anti-PD-1 mAb) in patients with advanced solid tumors: Updated results from the phase Ia/Ib dose-escalation study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2650-2650

2022

Volltextzugriff (PDF)

Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine

Vaccine, 2009-03, Vol.27 (12), p.1869-1874

2009

Volltextzugriff (PDF)

Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition)

Journal of hematology and oncology, 2019-02, Vol.12 (1), p.16-11, Article 16

2019

Volltextzugriff (PDF)

Laribacter hongkongensis anaerobic adaptation mediated by arginine metabolism is controlled by the cooperation of FNR and ArgR

Environmental microbiology, 2017-03, Vol.19 (3), p.1266-1280

2017

Volltextzugriff (PDF)

The efficacy and safety of anlotinib in refractory colorectal cancer: A double-blinded, placebo controlled, randomized phase III ALTER0703 trial

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.65-65

2021

Volltextzugriff (PDF)

Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)

Journal of cancer research and clinical oncology, 2019-03, Vol.145 (3), p.725-736

2019

Volltextzugriff (PDF)

Chromosome-Level Genome Assembly of Cyrtotrachelus buqueti and Mining of Its Specific Genes

Frontiers in ecology and evolution, 2021-10, Vol.9

2021

Volltextzugriff (PDF)

Efficacy, Safety, and Immunogenicity of HLX04 Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment for Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase III Study

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2021-07, Vol.35 (4), p.445-458

2021

Volltextzugriff (PDF)

Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies

Diagnostic pathology, 2013-02, Vol.8 (1), p.27-27, Article 27

2013

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(23)
Humans
(16)
Oncology
(12)
China - Epidemiology
(8)
China
(7)
Adult
(6)
Female
(6)
Male
(6)
Middle Aged
(6)
Retrospective Studies
(5)
Aged
(4)
Animals
(4)
Biological And Medical Sciences
(4)
Schistosomiasis
(4)
Snails - Parasitology
(4)
Agriculture
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Cardiovascular System & Cardiology
(3)
Colorectal Cancer
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

8051 soc design based on fpga

Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial

A Strategy to Control Transmission of Schistosoma japonicum in China

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

2019 Chinese Hypertension League guidelines on home blood pressure monitoring

2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

Analysis of Protein Expression Patterns of Silkworm Jinqiu and Its Cross Parents

Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial

Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study

Transarterial Chemoembolization Using 100-μm Drug-Eluting Microspheres in Patients with Hepatocellular Carcinoma: A Prospective Study and Midterm Follow-up

Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double‐Blinded, Placebo‐Controlled, Randomized Phase III Trial (ALTER0703)

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma

Phase Ia/Ib dose-escalation study of IBI110 (anti-LAG-3 mAb) as a single agent and in combination with sintilimab (anti-PD-1 mAb) in patients (pts) with advanced solid tumors

Efficacy and safety of IBI110 (anti-LAG-3 mAb) in combination with sintilimab (anti-PD-1 mAb) in first-line advanced squamous non-small cell lung cancer (sqNSCLC): Initial results from a phase Ib study

IBI110 (anti-LAG-3 mAb) as a single agent or in combination with sintilimab (anti-PD-1 mAb) in patients with advanced solid tumors: Updated results from the phase Ia/Ib dose-escalation study

Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine

Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition)

Laribacter hongkongensis anaerobic adaptation mediated by arginine metabolism is controlled by the cooperation of FNR and ArgR

The efficacy and safety of anlotinib in refractory colorectal cancer: A double-blinded, placebo controlled, randomized phase III ALTER0703 trial

Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)

Chromosome-Level Genome Assembly of Cyrtotrachelus buqueti and Mining of Its Specific Genes

Efficacy, Safety, and Immunogenicity of HLX04 Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment for Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase III Study

SALIRI‐based (raltitrexed plus irinotecan) therapy as a second‐line treatment for patients with metastatic colorectal cancer (SALLY): A prospective, multicenter, non‐interventional, registry study

Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies

Suchergebnisse filtern